A citation-based method for searching scientific literature

Evan J Walker, Julia Carnevale, Christina Pedley, Amie Blanco, Salina Chan, Eric A Collisson, Margaret A Tempero, Andrew H Ko. Fam Cancer 2019
Times Cited: 5







List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Margaret A Tempero, Mokenge P Malafa, Mahmoud Al-Hawary, Horacio Asbun, Andrew Bain, Stephen W Behrman, Al B Benson, Ellen Binder, Dana B Cardin, Charles Cha,[...]. J Natl Compr Canc Netw 2017
451
40

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer.
Talia Golan, Pascal Hammel, Michele Reni, Eric Van Cutsem, Teresa Macarulla, Michael J Hall, Joon-Oh Park, Daniel Hochhauser, Dirk Arnold, Do-Youn Oh,[...]. N Engl J Med 2019
487
40

Identification of germline genetic mutations in patients with pancreatic cancer.
Erin E Salo-Mullen, Eileen M O'Reilly, David P Kelsen, Asad M Ashraf, Maeve A Lowery, Kenneth H Yu, Diane L Reidy, Andrew S Epstein, Anne Lincoln, Amethyst Saldia,[...]. Cancer 2015
98
40

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
David B Zhen, Kari G Rabe, Steven Gallinger, Sapna Syngal, Ann G Schwartz, Michael G Goggins, Ralph H Hruban, Michele L Cote, Robert R McWilliams, Nicholas J Roberts,[...]. Genet Med 2015
134
40

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
Michael Goggins, Kasper Alexander Overbeek, Randall Brand, Sapna Syngal, Marco Del Chiaro, Detlef K Bartsch, Claudio Bassi, Alfredo Carrato, James Farrell, Elliot K Fishman,[...]. Gut 2020
82
40

Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer.
Robert C Grant, Iris Selander, Ashton A Connor, Shamini Selvarajah, Ayelet Borgida, Laurent Briollais, Gloria M Petersen, Jordan Lerner-Ellis, Spring Holter, Steven Gallinger. Gastroenterology 2015
162
40

Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer.
Nicholas J Roberts, Alexis L Norris, Gloria M Petersen, Melissa L Bondy, Randall Brand, Steven Gallinger, Robert C Kurtz, Sara H Olson, Anil K Rustgi, Ann G Schwartz,[...]. Cancer Discov 2016
159
40

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.
Matthew B Yurgelun, Anu B Chittenden, Vicente Morales-Oyarvide, Douglas A Rubinson, Richard F Dunne, Margaret M Kozak, Zhi Rong Qian, Marisa W Welch, Lauren K Brais, Annacarolina Da Silva,[...]. Genet Med 2019
67
40

Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma.
Koji Shindo, Jun Yu, Masaya Suenaga, Shahriar Fesharakizadeh, Christy Cho, Anne Macgregor-Das, Abdulrehman Siddiqui, P Dane Witmer, Koji Tamura, Tae Jun Song,[...]. J Clin Oncol 2017
157
40

Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms.
Maeve A Lowery, Winston Wong, Emmet J Jordan, Jonathan W Lee, Yelena Kemel, Joseph Vijai, Diana Mandelker, Ahmet Zehir, Marinela Capanu, Erin Salo-Mullen,[...]. J Natl Cancer Inst 2018
73
40

Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Elena M Stoffel, Shannon E McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M Petersen, Diane M Simeone, Matthew Yurgelun,[...]. J Clin Oncol 2019
46
40

Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history.
Kari G Chaffee, Ann L Oberg, Robert R McWilliams, Neil Majithia, Brian A Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, Richard J Wenstrup, Gloria M Petersen. Genet Med 2018
52
40

Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Carol Cremin, Michael Kuan-Ching Lee, Quan Hong, Carolyn Hoeschen, Anna Mackenzie, Katherine Dixon, Mary McCullum, Jennifer Nuk, Steve Kalloger, Joanna Karasinska,[...]. Cancer Med 2020
7
40

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.
Randall Brand, Erkut Borazanci, Virginia Speare, Beth Dudley, Eve Karloski, Mary Linton B Peters, Lindsey Stobie, Nathan Bahary, Herbert Zeh, Amer Zureikat,[...]. Cancer 2018
30
40

Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
A Letessier, S Garrido-Urbani, C Ginestier, G Fournier, B Esterni, F Monville, J Adélaïde, J Geneix, L Xerri, P Dubreuil,[...]. Oncogene 2007
66
20

Clinical relevance of screening checklists for detecting cancer predisposition syndromes in Asian childhood tumours.
Sock Hoai Chan, Winston Chew, Nur Diana Binte Ishak, Weng Khong Lim, Shao-Tzu Li, Sheng Hui Tan, Jing Xian Teo, Tarryn Shaw, Kenneth Chang, Yong Chen,[...]. NPJ Genom Med 2018
6
20

The Pten-Parkin Axis: At the Nexus of Cancer and Neurodegeneration.
Nathan T Ihle, Robert T Abraham. Mol Cell 2017
6
20

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
D Williams Parsons, Angshumoy Roy, Yaping Yang, Tao Wang, Sarah Scollon, Katie Bergstrom, Robin A Kerstein, Stephanie Gutierrez, Andrea K Petersen, Abhishek Bavle,[...]. JAMA Oncol 2016
217
20

Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma.
David A Solomon, Jung-Sik Kim, Julia C Cronin, Zita Sibenaller, Timothy Ryken, Steven A Rosenberg, Habtom Ressom, Walter Jean, Darell Bigner, Hai Yan,[...]. Cancer Res 2008
90
20

Germline Mutations in Predisposition Genes in Pediatric Cancer.
Jinghui Zhang, Michael F Walsh, Gang Wu, Michael N Edmonson, Tanja A Gruber, John Easton, Dale Hedges, Xiaotu Ma, Xin Zhou, Donald A Yergeau,[...]. N Engl J Med 2015
494
20

Oncogenic mutations of ALK kinase in neuroblastoma.
Yuyan Chen, Junko Takita, Young Lim Choi, Motohiro Kato, Miki Ohira, Masashi Sanada, Lili Wang, Manabu Soda, Akira Kikuchi, Takashi Igarashi,[...]. Nature 2008
594
20

Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes.
James Whitworth, Philip S Smith, Jose-Ezequiel Martin, Hannah West, Andrea Luchetti, Faye Rodger, Graeme Clark, Keren Carss, Jonathan Stephens, Kathleen Stirrups,[...]. Am J Hum Genet 2018
25
20

PARKIN Inactivation Links Parkinson's Disease to Melanoma.
Hui-Han Hu, Caroline Kannengiesser, Suzanne Lesage, Jocelyne André, Samia Mourah, Laurence Michel, Vincent Descamps, Nicole Basset-Seguin, Martine Bagot, Armand Bensussan,[...]. J Natl Cancer Inst 2015
48
20

Expanding the phenotype of mutations in DICER1: mosaic missense mutations in the RNase IIIb domain of DICER1 cause GLOW syndrome.
Steven Klein, Hane Lee, Shahnaz Ghahremani, Pamela Kempert, Mariam Ischander, Michael A Teitell, Stanley F Nelson, Julian A Martinez-Agosto. J Med Genet 2014
40
20

SLFN11 inhibits checkpoint maintenance and homologous recombination repair.
Yanhua Mu, Jiangman Lou, Mrinal Srivastava, Bin Zhao, Xin-hua Feng, Ting Liu, Junjie Chen, Jun Huang. EMBO Rep 2016
68
20

Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.
Yunyun Jiang, Filip Janku, Vivek Subbiah, Laura S Angelo, Aung Naing, Peter M Anderson, Cynthia E Herzog, Siqing Fu, Robert S Benjamin, Razelle Kurzrock. Oncotarget 2013
19
20

SLFN11 can sensitize tumor cells towards IFN-γ-mediated T cell killing.
Riccardo Mezzadra, Marjolein de Bruijn, Lucas T Jae, Raquel Gomez-Eerland, Anja Duursma, Ferenc A Scheeren, Thijn R Brummelkamp, Ton N Schumacher. PLoS One 2019
14
20

The Schlafen family: complex roles in different cell types and virus replication.
Furao Liu, Pingting Zhou, Qian Wang, Meichao Zhang, Dong Li. Cell Biol Int 2018
22
20

DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies.
Kris Ann P Schultz, Gretchen M Williams, Junne Kamihara, Douglas R Stewart, Anne K Harris, Andrew J Bauer, Joyce Turner, Rachana Shah, Katherine Schneider, Kami Wolfe Schneider,[...]. Clin Cancer Res 2018
112
20

Recognition of genetic predisposition in pediatric cancer patients: An easy-to-use selection tool.
Marjolijn C J Jongmans, Jan L C M Loeffen, Esmé Waanders, Peter M Hoogerbrugge, Marjolijn J L Ligtenberg, Roland P Kuiper, Nicoline Hoogerbrugge. Eur J Med Genet 2016
52
20


SLFN11 Blocks Stressed Replication Forks Independently of ATR.
Junko Murai, Sai-Wen Tang, Elisabetta Leo, Simone A Baechler, Christophe E Redon, Hongliang Zhang, Muthana Al Abo, Vinodh N Rajapakse, Eijiro Nakamura, Lisa M Miller Jenkins,[...]. Mol Cell 2018
92
20

Recognizing and Managing Children with a Pediatric Cancer Predisposition Syndrome: A Guide for the Pediatrician.
Stephanie A Coury, Katherine A Schneider, Jaclyn Schienda, Wen-Hann Tan. Pediatr Ann 2018
3
33

SOX4 promotes melanoma cell migration and invasion though the activation of the NF-κB signaling pathway.
Qiong Cheng, Jinfeng Wu, Yaohua Zhang, Xiao Liu, Nan Xu, Fuguo Zuo, Jinhua Xu. Int J Mol Med 2017
19
20

Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation.
Xudong Wang, Haizhu Wang, Shutao Zhao, Pengda Sun, Dacheng Wen, Tianzhou Liu, Hao Liu, Zecheng Yang, Zhiming Ma. Tissue Cell 2018
6
20

Immune Cytolytic Activity Stratifies Molecular Subsets of Human Pancreatic Cancer.
David Balli, Andrew J Rech, Ben Z Stanger, Robert H Vonderheide. Clin Cancer Res 2017
98
20

Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer.
May Tun Saung, Stephen Muth, Ding Ding, Dwayne L Thomas, Alex B Blair, Takahiro Tsujikawa, Lisa Coussens, Elizabeth M Jaffee, Lei Zheng. J Immunother Cancer 2018
22
20

Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations.
Xuewen Liu, Yuxia Jia, Mark B Stoopler, Yufeng Shen, Haiying Cheng, Jinli Chen, Mahesh Mansukhani, Sanjay Koul, Balazs Halmos, Alain C Borczuk. J Clin Oncol 2016
189
20

Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, Marcel P Trefny, Seth Garren, Cécile Piot, Camilla Engblom, Christina Pfirschke, Marie Siwicki, Jeremy Gungabeesoon,[...]. Immunity 2018
244
20

CD47-CAR-T Cells Effectively Kill Target Cancer Cells and Block Pancreatic Tumor Growth.
Vita Golubovskaya, Robert Berahovich, Hua Zhou, Shirley Xu, Hizkia Harto, Le Li, Cheng-Chi Chao, Mike Ming Mao, Lijun Wu. Cancers (Basel) 2017
27
20

Production of IL-10 by CD4(+) regulatory T cells during the resolution of infection promotes the maturation of memory CD8(+) T cells.
Brian J Laidlaw, Weiguo Cui, Robert A Amezquita, Simon M Gray, Tianxia Guan, Yisi Lu, Yasushi Kobayashi, Richard A Flavell, Steven H Kleinstein, Joe Craft,[...]. Nat Immunol 2015
106
20

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
Chin-King Looi, Felicia Fei-Lei Chung, Chee-Onn Leong, Shew-Fung Wong, Rozita Rosli, Chun-Wai Mai. J Exp Clin Cancer Res 2019
46
20

CAR T-cell therapy for pancreatic cancer.
Carl J DeSelm, Zachary E Tano, Anna M Varghese, Prasad S Adusumilli. J Surg Oncol 2017
38
20

Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodies.
Victoria M Kim, Alex B Blair, Peter Lauer, Kelly Foley, Xu Che, Kevin Soares, Tao Xia, Stephen T Muth, Jennifer Kleponis, Todd D Armstrong,[...]. J Immunother Cancer 2019
20
20

Driving CARs on the uneven road of antigen heterogeneity in solid tumors.
Nan Chen, Xiaoyu Li, Navin K Chintala, Zachary E Tano, Prasad S Adusumilli. Curr Opin Immunol 2018
31
20

Oncolytic viral therapy for pancreatic cancer.
Ahmad Rahal, Benjamin Musher. J Surg Oncol 2017
22
20

Therapeutic developments in pancreatic cancer: current and future perspectives.
John P Neoptolemos, Jörg Kleeff, Patrick Michl, Eithne Costello, William Greenhalf, Daniel H Palmer. Nat Rev Gastroenterol Hepatol 2018
279
20

The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
Laetitia Marisa, Magali Svrcek, Ada Collura, Etienne Becht, Pascale Cervera, Kristell Wanherdrick, Olivier Buhard, Anastasia Goloudina, Vincent Jonchère, Janick Selves,[...]. J Natl Cancer Inst 2018
57
20

Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.
Dung T Le, Andrea Wang-Gillam, Vincent Picozzi, Tim F Greten, Todd Crocenzi, Gregory Springett, Michael Morse, Herbert Zeh, Deirdre Cohen, Robert L Fine,[...]. J Clin Oncol 2015
313
20

WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study.
Ryu Yanagisawa, Tomonobu Koizumi, Terutsugu Koya, Kenji Sano, Shigeo Koido, Kazuhiro Nagai, Masanori Kobayashi, Masato Okamoto, Haruo Sugiyama, Shigetaka Shimodaira. Anticancer Res 2018
21
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.